THE STUDY OF KEY SUCCESSFUL FACTORS ON FOOD
BIOTECHNOLOGY INDUSTRY IN TAIWAN
Ming-Lang Wang1, *, Kang-Wei Wang
2
1Department of Industrial Management, Chung Hua University, Associate Professor
30012, No.707, Sec.2, Wu-Fu Rd., Hsinchu City, Taiwan, R.O.C.
2Medical Affairs Bureau Ministry of National Defense, Director, Comptroller Office
10462, No.409, Bei-An Rd., Taipei City 104, Republic of China (Taiwan)
*Corresponding author [email protected]
Abstract
Biotechnology industry is one of the most valued industries in the future, covering agriculture, food, health care,
environmental protection, mechanical and electrical information, materials and chemical industries. From these fields, the
biotechnology industry has become part of our lives. Not only has Taiwan actively promoted the biotechnology industry
to become a major industry, but countries around the world have also listed biotechnology industries as a priority boosted
industry. In recent years, in response to the issue of the "Food safety storm", Taiwan has formulated relevant regulations
and combined with the R&D of the biotechnology industry, so that the public can eat food with peace of mind. First of all,
this research aims to explore the key factors affecting the development of Taiwan's food biotechnology industry, and to
explore the trend of this industry and key issues through interviews with experts and questionnaire surveys of industry
stakeholders; Secondly, at the same time, through the integration of expert interviews and analysis of questionnaire results,
we have a better understanding of the trend and vision of the food biotechnology industry, and put forward relevant
conclusions on the research topics based on various theories and analysis results. Finally, the study found that there are
four key factors affecting the food biotechnology industry development in Taiwan which are: (1) funds investment in
research and development, (2) understanding of consumers’ demand, (3) how to maintain competitive edge in the market,
(4) the support of government policy (ex. funds support and promotion).
Keywords: Key Successful Factors; Biotechnology Industry; Food Biotechnology; Industrial Trends
Ming-Lang Wang, Kang-Wei Wang, Int. Jou Eco. Res, 2020, V11 i1, 79 – 98 ISSN:2229-6158
IJER –January -February 2020 available online @ www.ijeronline.com
79
1. Introduction
To make the biotechnology industry
becomes one of Taiwan's emerging industries. In
recent years, Taiwan has successively promoted
various measures to assist the development of
the biotechnology industry. In February 1996,
the "Ministry of Economic Affairs
Biotechnology and Pharmaceutical Industry
Development Promotion Group" was established.
The primary purpose of this promotion group is
to act as a channel for communication,
coordination and integration of various
departments. In the same year, the National
Health Research Institutes were established and
the National Health Research Institutes were
established, too. The foundation of the
biotechnology industry has been strengthened
(Julie C.L. Sun, 2003). Simultaneously, Council
for Economic Planning and Development
(Executive Yuan)、National Science Council
and Council of Agriculture set up biotechnology
parks in the northern, central, and southern
regions of Taiwan to strengthen regional
development and effectively increase regional
capabilities and technologies.
After nearly two decades of efforts, there
has been a remarkable growth in Taiwan's
biotech industry with actively promoting by both
public and private sectors. In 2014, the total
revenue of biotech industry in Taiwan was NT $
288.6 billion. The total market capitalization of
all listed companies in biotech industry over that
of the total market increased from 0.85% in
2010 to 2.16% in 2014. With the efforts of the
government and the industry, the revenue of
biotech industry increased 51%, comparing NT
$ 191.2 billion in 2007. Applied Biotechnology
Industry can be divided into five major areas:
food biotechnology, agricultural biotechnology,
environmental biotechnology, specialized
biotechnology and biotechnology service
industries. Applied biotech industry increased to
NT$ 82.2 billion in 2014, from NT$ 38.6 billion
in 2005. The compound annual growth rate is
about 8.76%, which is the fastest growing
industry, included the fast growing health food
and health sector, driven the growth of applied
biotechnology industry (Jia-Yi Fan, 2016).
The overall view of the current status of
Taiwan's biotechnology industry, both the
government and academia believe that the
promotion of policies related to the
biotechnology industry and the bio-economy
needs to strengthen cross-ministerial
coordination, and to reinforce cross-sectoral
resource sharing, information circulation, and
the expansion of biotechnology to agriculture,
industry, health and other fields. As far as the
current development trend of Taiwan's
biotechnology industry is concerned, Taiwan has
advanced agricultural technology, such as
cultivation technology, breeding technology,
biological science, etc., can be combined with
"productivity 4.0" by sensing technology、
intelligent robot (IR) 、 Internet of Things
(IoTs)、Big data analysis and other forward-
looking technologies. Construct a smart
production 、 marketing and digital service
system to increase the value-added of applied
biotechnology industries such as agriculture,
food, and environmental biotechnology.
With the gradual improvement of
biotechnology industry structure, the capital
market has also injected sufficient funds into the
biotechnology industry, which has increased the
amount of investment in the biotechnology
industry year by year. In the future, it will be line
up with biotechnology policies and various
investment incentives provided by the
Ming-Lang Wang, Kang-Wei Wang, Int. Jou Eco. Res, 2020, V11 i1, 79 – 98 ISSN:2229-6158
IJER –January -February 2020 available online @ www.ijeronline.com
80
government to encourage domestic and foreign
manufacturers to invest in Taiwan, and assist in
raising R&D and operating funds to accelerate
the development of biotechnology industry.
Simultaneously, according to the domestic and
foreign biotechnology industry development
profiles, the industry will complete the blueprint
of the biotechnology industry development and
developing three major strategies, including
developing featured products, and creating
flagship companies, and expanding investment.
It is expected that the revenue of the
biotechnology industry will reach NT $ 500
billion by 2020, 5 flagship biotechnology
companies with revenue of NT $ 10 billion will
be born, and Taiwan will become a hub, well-
known for distinctive product and high-quality
technology in biotechnology and medicine
internationally (Biotechnology Industry in
Taiwan, 2015).
At present, many countries are enhancing
economic construction and development, hoping
to develop biotechnology industry with high
added value, low pollution, and high economic
benefits. The biotechnology industry has been
listed as a national key sector for development.
Taiwan also actively promotes the biotechnology
industry, and has set up biotechnology industrial
parks in the northern, central, and southern
regions. It is hoped that the clustering effect of
the industry can be brought into play, and
expected that the planning of the biotechnology
park will allow companies to assist in research,
strengthen the basic structure of industrial
development, and also balance the development
of Taiwan's biotechnology industry.
As the biotechnology industry covers a
wide range, and food biotechnology is closely
related to our lives, "eating" is no longer purely
to intake what our body needed, but also
includes related health foods derived from the
need for physical health. Research and
development of these related products not only
make the company profit, but also improve
people's health and prevent physical diseases in
advance. This research takes Company B as an
example. The purpose of this study is to
understand the current development status of the
food biotechnology industry, and to understand
the development process of the company by
interviewing the professional managers of
Company B. This study will explore the
development and prospects of the food
biotechnology industry based on theories of
expert interviews and questionnaire surveys of
industry professionals.
2. Literatures Review
This chapter explores the use of the
biotechnology industry in life. The applied
biotechnology industry is one of the three main
industries in biopharmaceuticals. The applied
biotechnology industry covers 7 areas –
regenerative medicine, food biotechnology,
agricultural biotechnology, special biochemicals,
biopharmaceutical services, environmental
biotechnology, and emerging biotechnology. The
object of this study is the food biotechnology
industry, which is one of the areas of applied
biotechnology industry (Yearbook of Applied
Biotechnology Industry, 2016). According to the
Yearbook of Applied Biotechnology Industry,
the scope of products and services includes: (1)
microbial nutrition health products; (2)
functional ingredients nutrition health products.
This study explores the current status and vision
of Taiwan's food biotechnology industry with
three core frameworks: future development,
industry SWOT analysis, and strategic planning.
Then, it explores why the biotechnology
industry is so important in the economic system
Ming-Lang Wang, Kang-Wei Wang, Int. Jou Eco. Res, 2020, V11 i1, 79 – 98 ISSN:2229-6158
IJER –January -February 2020 available online @ www.ijeronline.com
81
(Biotechnology Industry in Taiwan, 2011).
According to the Department of Health
announced that apply for healthy foods good for
health (including controlling blood lipid,
improving gastrointestinal function, dental
health, and immune system, reversing
osteoporosis, preventing aging, controlling blood
sugar, anti-fatigue, and promoting iron
absorption etc.,). Improving gastrointestinal
function and controlling of blood lipid are the
main items for manufacturers to apply for
certification. Anti-fatigue, reversing osteoporosis,
and promoting iron absorption are newly applied
items for manufacturers. As the government
gradually opens up certification programs, the
number of certifications will continue to increase,
and it will also attract biotechnology and
pharmaceutical manufacturers to invest in the
development and certification of healthy foods
(Biotechnology Industry in Taiwan, 2009).
Due to the development of modern medical
technology, Taiwan is gradually moving towards
an aging society. With the increase of the elderly
population, the demand for related health foods
has increased (Fann & Hsu, 2010). The total
consumption of health food increased to NT$
188.4 billion in 2014 from $ 156 billion in 2013.
Kircher et al., (2004) pointed out that the elders
are more likely require more nutritious, healthier
and softer food because they need special
nutrition and requirements. In response to the
advent of today's people's focus on healthy diets
and the advent of an aging society, the
government has also actively developed related
health foods and formulated related health needs
and diet analysis policies for the elderly.
Secondly, the rapid development and
commercialization of Genetically Modified
Organisms (GMO) has become the focus of
international concern in recent years. APEC and
WTO and other international conferences
continue to discuss this related issue. Early
genetically modified crops were mainly resistant
to herbicides and pests. Recently, genetically
modified crops with improving nutritional
quality have gradually appeared in market. Their
demands have expanded from farmers to
consumers. Food and nutrition-related industries
have inevitably had to pay attention to this trend
(Chii-Cherng Liao, 2005). The "Summary of
analysis of domestic health food output value
and industry in 2011" proposed that any health
foods or functional foods that provide special
physiological functions and health effects are in
the scope of health foods. In addition to "health
foods" certified by the Department of Health,
"functional foods" with special functions,
"dietary supplements" that supplement nutrients,
and "special nutritional foods" that meet the
needs of special physiological conditions, such
as foods for patients. Therefore, health foods
are not limited to "health foods" certified by the
Department of Health. In the broadest definition,
any health foods provide health or functional
effects are in the scope of biotech foods.
Although this definition is somewhat different
from the biotech food of this study, it is roughly
similar to each other (Shu-Yen Chiang, 2015).
Taking food biotechnology as an example, food
is indispensable in our daily life, and all
countries attach great importance to it.
Government departments actively combine the
food and biotechnology industries to develop
health foods and lactic acid bacteria functional
foods for the general public for safety and
healthy.
2.1 Definition of Biotechnology
Alison L. Van Eenennaam
(2017) argued the scope of biotechnology covers
using biological procedures including biological
Ming-Lang Wang, Kang-Wei Wang, Int. Jou Eco. Res, 2020, V11 i1, 79 – 98 ISSN:2229-6158
IJER –January -February 2020 available online @ www.ijeronline.com
82
cell characteristics, components or metabolites
from microorganisms, plants, or animals etc. to
make products, or applying molecular-level
technologies to improve traditional production
procedures, and the science of improving human
life (Biotechnology Industry White Paper, 2015).
There are different international definitions of
biotechnology, for example: The United Nations
Convention on Biological
Diversity (CBD) defines biotechnology as
"biotechnology is the use of biological systems,
living organisms or derivatives to produce or
modify products for specific uses, or any
application technology of the process." OECD,
consist of the United States, Canada, Japan,
Britain, the European Union and
other 30 countries, defined biotechnology as "the
application of science and technology to living
organisms as well as parts, products and models
thereof, to alter living or non-living materials for
the production of knowledge, goods and
services. Industrial Development Bureau, in
accordance with the world trend of opinions,
defined biotechnology as "the use of molecular
biology, cell biology, immunology, genomics
and proteomics and other life science and
genetic engineering, protein engineering, cell
engineering based on technologies such as tissue
engineering, science and technology for research
and development, manufacturing or improving
product quality to improve the quality of human
life" ( Biotechnology Industry in
Taiwan , 2015) . Raju P. (2016) claimed
that biotechnology is the concept upon technical
level, which can be applied to various traditional
industries and emerging areas. It is not easy
define due to the indistinguishable scope of the
industrial sub-sectors.
Due to the wide range of technical
applications and different classifications, there
are many industries that can be introduced and
combined with biotechnology. Most of them
involve organisms at the level of manufacturing
or technical applications. Among them, medicine,
agriculture and food are the main application,
but it does not mean these existing industries are
completely included in the biotechnology
industry. Additionally, the definition
biotechnology in Taiwan is not very clear, it has
caused some misunderstandings about
biotechnology (Jack J. Chen, 2001).
2.2 Food Biotechnology and Future
Development
Liao (2005) proposed that the food industry
is a sustainable and essential industry for
people's livelihood. Taiwan's annual food
consumption is about NT $ 1.5 trillion, of which
the catering industry is about NT $260 billion,
food processing is about NT $ 450 billion,
observed by long experience, although the food
industry output value will also change with the
socio-economic growth and decline. But
compared with other industries, the food
industry is relatively stable. Biotechnology is
one of the cutting-edge technologies following
petrochemical, aviation, nuclear energy, and
information in the 20th century. Its application
has expanded to the fields of medicine and
health care, food, agriculture, and environmental
protection, and it is the most promising
technology area in the 21st century. The
challenges it will face in 21st century includes:
(1). R&D trends in the food sector include
the following three key points:
1. Food safety, 2. The appeal of health
benefits and 3. Highly applied biotechnology.
(2). The application of biotechnology in
the food industry is as follows:
1.The scope of biotechnology applications in
the food industry, 2. The advantages of
Ming-Lang Wang, Kang-Wei Wang, Int. Jou Eco. Res, 2020, V11 i1, 79 – 98 ISSN:2229-6158
IJER –January -February 2020 available online @ www.ijeronline.com
83
biotechnology in the food industry, 3.
Improvement of food processing, 4.
Development of new products, 5. Improvement
of food quality and safety inspection, 6.
Treatment and utilization of food waste (Chii-
Cherng Liao, 2005).
2.3 Industrial Competitiveness (SWOT analysis)
This study applies SWOT analysis. The
analysis originated in 1980's and proposed by
Professor Heinz Weihrich in University of San
Francisco. Strengths and weaknesses analysis
focus on the strength of the company itself and
its comparison with competitors, while
opportunity and threat analysis focus on changes
in the external environment and possible impact
on the company. When conducting the analysis,
all internal factors (i.e. advantages and
disadvantages) should be brought together, and
then external factors should be used to evaluate
these external forces (MBA Encyclopedia,
SWOT Analysis, 2019).
Strengths: 1. Biotechnology industry talents,
2. Beauty and health food favored by
young people,
3. Across a wide age range in the
market.
Weakness: 1. Higher cost,
2. Longer period for food experiment,
3. Insufficient experience.
Opportunity: 1. Climbing demand for food due
to aging society,
2. More and more people attach
importance to food,
3. Government supports.
Threat: 1. Many competitors in the industry,
2. Many choices in market,
3. Genetic modification issues,
4. Food safety issues.
2.4 Strategic Planning
Comparing international standards of food
bio-economic development, the US National
Bio-economic Blueprint focuses on reducing
regulatory barriers, cultivating the talents,
strengthening research, accelerating
commercialization, and attaching importance to
food safety; Germany integrates biotechnology
and the food industry and attaches importance to
the development and application of bacteria and
food innovation; Japan’s “Cool Japan” strongly
promotes Japanese brands, expands overseas
markets, and builds the foundation for industrial
innovation. It empathizes on disease prevention
and universal design foods and other new
product development and sales, and at the same
time, it uses ICT such as electronics transaction
and cloud technology to stabilize food supply
(Board of Science and Technology, BOST, 2016).
In order to strengthen the management and
supervision of health foods and protect the rights
of consumers, the Ministry of Health and
Welfare in Taiwan announced the Health Food
Control Act in 1999. Unregistered food for
inspection shall not be named as health foods. At
the same time, the Ministry of Health and
Welfare also announced the evaluation of
healthy foods as a basis for manufacturers to
apply for health food review. The authority also
established health food specifications for Anka
and fish oil (Biotechnology Industry in Taiwan,
2015).
3. Research Methodology
This study adopts secondary analysis、
expert interview and questionnaire survey to
explore the vision of Taiwan's biotechnology
food industry development.
3.1 Secondary Data Analysis
Secondary data analysis is an analysis
method that further analyzes existing data to
Ming-Lang Wang, Kang-Wei Wang, Int. Jou Eco. Res, 2020, V11 i1, 79 – 98 ISSN:2229-6158
IJER –January -February 2020 available online @ www.ijeronline.com
84
derive conclusions or interpretations. The data
sources include research reports, industry
operating data, case studies, books, journals,
published data on the Internet, statistics
surveyed by the government and publications.
The use of data can provide the value as for the
researchers to develop the concept of research,
and sometimes it can be the actual data for
researchers to verify hypotheses, or for
exploratory research (Pei-Er Han, 1998). In
addition to the secondary data, the study
conducted expert interview and questionnaire
surveys. It is hoped to better understand the
future development trends and prospects of the
food biotechnology industry in Taiwan, and at
the same time explore the general situation of
the industry from various aspects, and get
relevant answers to in-depth questions (Ruo-
Huan Yu, 2004).
3.2 Expert Interview
An interview is a conversation between two
or more people. The essential requirement is that
there should be at least one interviewer and one
or more interviewees. In fact, an interview is a
method for gathering information. If properly
managed and arranged, the interviewer can
inquire about the other party's ideas and get the
answers they want. Besides, interviews can be
formal or informal, and can be stepped into the
core of the topic through the exploration of
structured, unstructured, or open-ended
questions. More mature topics can also be
explored through standard, structured or closed-
ended questions. As for in-depth interviews,
according to the definition of scholars (Yang et
al., 2000), in-depth interviews refer to obtaining
important factors through interviews, and these
important factors are not simply the results of
general face-to-face interviews.
The purpose of the in-depth interview is to
analyze the true insider, true meaning, impact,
future development and solution of the interview.
Generally speaking, in-depth interviews can take
more time than general interviews, but the
results obtained can more deeply describe the
nature of issue as a basis for further analysis.
However, the in-depth interview is mainly to
explore the true feelings of the interviewee. It
can be used for in-depth topics for journalists',
psychiatry, psychological counseling, education,
and ethnographic anthropology (Wan, 2004).
3.3 Interview with Food Biotechnology Industry
Company B
(1). What is the reason and motivation for your
company's establishment?
Answer: Company B was founded in 1999
with a capital of approximately NT $ 250
million. The first beginning B company
produced medical equipment. Under various
circumstances, the company will come into
contact with the biotechnology industry, and
then develop skin care products. Regarding food
biotechnology, in the beginning, the company
exported health products to the United States. It
was about 2012 that the local marketing
companies started to need foods with health
effects, so that company B was asked to develop
and produce health food.
(2). What is the biggest challenge the company
face in the early stage of operation? How did the
managers overcome the problems?
Answer: In beginning selling products to
the United States, Company B started with
capsule foods. When animal capsules were
imported into the United States, the United
States established strict food regulations due to
the previous outbreak of mad cow disease in the
United States. Company B spent nearly half a
year to understand the local regulations and the
relevant food regulations in the United States.
Ming-Lang Wang, Kang-Wei Wang, Int. Jou Eco. Res, 2020, V11 i1, 79 – 98 ISSN:2229-6158
IJER –January -February 2020 available online @ www.ijeronline.com
85
Finally, it solved the problems by understanding
the U.S. regulations.
3. Why the company built the factory in Hsinchu
Science Park? Are there any special
considerations?
Answer:Company B chose to set up a
factory in Hsinchu Science Park, mainly because
the technology industry is denser in this area.
Hsinchu Science Park has convenient
transportation. Additionally, there are National
Chiao Tung University, National Tsing Hua
University and Industrial Technology Research
Institute(ITRI). There are many talents, and it is
one of the major science and technology towns
in the country to develop high-tech foundry
industries. It has also gradually become the
center of science and technology industry in
northern Taiwan.
4. What is your major considering if need to
cooperate with external company?
Answer: Quality. According Company’s
perspective, if the products are poor in quality
from marketing, engineering, manufacturing to
customer retention, it will affect their purchase
intention. This is a negative impact for the
company. From the perspective of sustainable
operation, products with good quality is the
fundamental to maintain the company's image.
5. Based on your understanding of the future
development on the food biotechnology industry
in Taiwan,
which products have more potential?
Answer: As far as company B is concerned,
the Taiwan market is not optimistic, because the
market scale of Taiwan is too small. Healthy and
functional products have more potential to sell
abroad. In addition to health foods after illness,
the company also focus on health foods for
preventing disease in advance.
6. Does the certification of health foods mean
the quality assurance of health effects? Can it
increase trust for the public?
Answer: From the standpoint of company B,
the certification of health food is necessary. It is
necessary to obtain the certification of health
food first if declaring any effects of the product.
This is a basic regulatory requirement. It is
against the law if selling uncertificated products
in market. The company should increase the
public’s trust. After all, it is a nationally certified
food, and the people will feel safe to take it.
7. As far as you know, do Taiwan's health food
industry transferred technology abroad?
Answer: No, at present, because Taiwan
lacks raw materials, most of products rely on
imports, and foreign technologies are better than
domestic, so there is no technology transfer.
8. Is there a transformation of traditional
industries into biotechnology industries, and
then research and development on health foods?
Answer: As far as company B's experience
is concerned, there is no such issue at present,
because the machinery and equipment are
different, and the operator may have some
different concepts in the process of operation. In
practice, there have been no cases in which
traditional industries have been transformed into
biotechnology industries.
3.4 Questionnaire Survey
The questionnaire survey method is a
general and concrete operational process. It must
adopt objective and systematic scientific
methods. In application, it is necessary to
understand the implementation process and
sequence in order to collect reliable and effective
data (Ming-Qing Wu, 1991). This method allows
responders to answer in a convenient time, and
the questionnaire has anonymity, standardized
questions, and a wide range of implementation.
Ming-Lang Wang, Kang-Wei Wang, Int. Jou Eco. Res, 2020, V11 i1, 79 – 98 ISSN:2229-6158
IJER –January -February 2020 available online @ www.ijeronline.com
86
This study uses expert interview 、
secondary data analysis and literature review to
establish a research structure, and then through
the literature to explore the relevant information
and design questionnaire. It is hoped that the
results of the questionnaire survey will be used
to understand the trend and vision of the food
biotechnology industry in Taiwan, and how the
company will maintain a competitive edge and
competitiveness in the industry for future
evaluation and research. Through the initial test,
questionnaires are officially issued and collected,
and then use SPSS software to analyze. Beside,
this study adopts Likert 5-Points Scale, the
instrument was validated in advance through
several personal interviews with Food
Biotechnology Industry managers on site,
scoring the subjective cognition an "1" for very
unimportant, and a "5" for very important. The
questionnaire was issued between October 2019
and December 2019.
3.5 Analysis Method
The questionnaires were collected and
encoded for effective questionnaires. The SPSS
version 18.0, statistics software, was used for
data analysis. Descriptive statistics provide a
simple summary of the measured samples, and
the results are quantified. This result is part of
the statistical data that forms a broader content.
The data is organized and summarized to
describe the attributes of a certain group in order
to have an overall understanding of the general
characteristics of the data.
Reliability analysis, questionnaire
reliability refers to the reliability of the questions,
that is the measurement of error, and also the
consistency or stability of the test results as the
basis. Reliability measures include test-retest
reliability 、 split-half reliability 、 equivalent-
forms reliability and Cronbach’s α reliability,
etc. (Chou, 2002). Nunnally (1978) argues that
in exploratory studies, if the reliability is greater
than 0.7, it is acceptable.
Factor analysis is a technique used to
reduce the dimension of variables. Its main
purpose is to reduce multiple variables
(dimensions) in original data to a smaller
number of dimensions, and to maintain the most
information provided by the original data. After
reducing the number of variables, it is easier to
explain or plot in subsequent research reports. It
can also be used for various tests, or as the basis
for discriminant analysis, cluster analysis, and
etc. in later stage. Therefore, the factor analysis
result is usually not the final analysis result of
the report; it is only an intermediate process to
condense the variables needed for the further
analysis (Shi-Ying Yang, 2015).
Principal component analysis aims to use
the idea of dimensionality reduction to convert
multiple indicators into a few comprehensive
indicators. In statistics, principal components
analysis (PCA) is often used to reduce the
dimension of the data set while maintaining
the feature that the data set has the greatest
contribution. In the management strategy, in
order to make the proper decision, a set of
variables is often used to judge whether the
decision is executable, but the variable needs
to be observed multiple times before it can be
obtained. Therefore, we replace the old
variable with some new variables, so that the
new set of variables can reflects most out of
the old one.
3.6 Research Structure
The study adopts case study and enterprise
questionnaire collection. The biotechnology
industry data is obtained through literature
review. The following is the diagram research
structure.
Ming-Lang Wang, Kang-Wei Wang, Int. Jou Eco. Res, 2020, V11 i1, 79 – 98 ISSN:2229-6158
IJER –January -February 2020 available online @ www.ijeronline.com
87
Figure 3-1. Research structure
4. Data Analysis
Questionnaire issue period is from October
2019 and December 2019. A total of 180
anonymous questionnaires were sent, and 56 valid
questionnaires were found after deducting the
damaged and ones with incomplete answers. The
effective recovery rate was 31.11%, and then use
SPSS 18.0 software to analyze and understand the
current and future trends and visions of Taiwan's
food biotechnology industry. The following are
the results of our analysis.
Competitive advantage of
biotechnology products in market
Promotion & development of food
biotechnology industry
R&D expenditure
Customer’s need for effects of
product
Management expectation for future
development of bioecology industry
Key factors for food biotechnology industry
Ming-Lang Wang, Kang-Wei Wang, Int. Jou Eco. Res, 2020, V11 i1, 79 – 98 ISSN:2229-6158
IJER –January -February 2020 available online @ www.ijeronline.com
88
4.1 Reliability Analysis
Table. 4-1 Reliability Analysis
According to the analysis above, the Cronbach's
Alpha of the questionnaire is 0.834, indicating
that the reliability level is quite good. Nunnally
(1978) is often associated with the assertion that
instruments used in exploratory research should
have reliability of .70 or better. The Cronbach's
Alpha at the right side of each variable means the
change of total reliability level if removing that
variable. If the range of change is small, that
variable should not be removed.
4.2 Descriptive Statistics
Table 4-2 Sales Region Descriptive Statistics
According to the results of the questionnaire,
Taiwan’s biotechnology foods mainly are
exported overseas. The major market is Americas,
followed by Europe and Asia.
4.3 Factor Analysis
Criteria: With KMO=0.873(mediocre > 0.6),
First take the absolute value of factor loadings
>0.45, then take eigenvalues >1.
Cronbach's Alpha
Adjusted Cronbach's Alpha by
standardized variable The number of variables
.834 .831 30
Sales Region Frequency Percentage(%) Effective Percentage Cumulative
Percentage
Europe 14 25.0 25.0 25.0
Americans 37 66.1 66.1 91.1
Asia (including
China)
5 8.9 8.9 100.0
Total 56 100.0 100.0 100.0
Ming-Lang Wang, Kang-Wei Wang, Int. Jou Eco. Res, 2020, V11 i1, 79 – 98 ISSN:2229-6158
IJER –January -February 2020 available online @ www.ijeronline.com
89
Table 4-3 Principal component analysis of the important factors for technological innovation and new
product development
Table. 4-4 Results of principal component analysis of R & D expenditures as important factors for
technological innovation and new product development (Factor Renaming)
Factor 1: Mainly composed of three highly
relevant variables, such as “Expansion of R&D
units”、 “Introduction of related technologies”
and “Training for R&D talents”. Because the
factor loading of the first two factors is higher and
more relevant, so this factor is named “Factors of
R&D technology ". The factor loadings are
between 0.714 and 0.838, the eigenvalue is 1.785,
and the explained variance is 44.631%.
Factor 2: Only includes “equipment update”.
The factor loading is 0.951 and the eigenvalue is
1.08, and the explained variance is 26.999%, so
this factor is named as "equipment factor". The
total explained variance of factor 1 and factor 2 is
71.63%.
Variable Factor 1 Factor 2
Training for R&D talents 0.714 0.19
Expansion of R&D units 0.838 0.044
Introduction of related technologies 0.751 -0.381
Equipment upgrade 0.047 0.951
Name of Factor Factor loading Eigenvalue Explained variance
1. Technical talents
Expansion of R&D units 0.838
1.785 44.631% Introduction of related technologies 0.751
Training for R&D talents 0.714
2. Equipment
Equipment upgrade 0.951 1.08 26.999%
Ming-Lang Wang, Kang-Wei Wang, Int. Jou Eco. Res, 2020, V11 i1, 79 – 98 ISSN:2229-6158
IJER –January -February 2020 available online @ www.ijeronline.com
90
Table. 4-5 Principal component analysis of consumer demand factors for different product functions
Variable Factor 1 Factor 2 Factor 3
Control blood lipid 0.096 0.762 -0.222
Improve gastrointestinal function 0.086 0.854 0.224
Reverse osteoporosis 0.444 0.638 0.099
Dental care 0.681 0.433 0.007
Improve immune system 0.794 -0.038 -0.085
Control blood sugar 0.782 0.393 -0.032
Improve liver function 0.663 -0.003 0.484
Anti-fatigue -0.075 -0.422 0.621
Prevent aging 0.042 0.268 0.827
Table. 4-6 Results of Principal Component Analysis of Consumer Demand Factors for Different Product Functions (Factor Renaming)
Name of Factor Factor loading Eigenvalue Explained variance
1. Prevent and maintain body function
Improve immune system 0.794 3.404 37.823%
Control blood sugar 0.782
Dental care 0.681
Improve liver function 0.663
2. Basic health care factors
Improve gastrointestinal function 0.854
1.511 16.785% Control blood lipid 0.762
Reverse osteoporosis 0.638
3. Maintain vitality factor
Prevent aging 0.827
1.183 13.142%
Anti-fatigue 0.621
Ming-Lang Wang, Kang-Wei Wang, Int. Jou Eco. Res, 2020, V11 i1, 79 – 98 ISSN:2229-6158
IJER –January -February 2020 available online @ www.ijeronline.com
91
Factor 1: There are 4 variables in factor 1, such
as "improving immune function"、"controlling
blood sugar" 、”dental care” and , “improve
liver function”. Because the factor loading of the
first two factors is higher and more relevant, so
this factor is named " Prevent and maintain body
function". The factor loadings are between 0.663
and 0.794, the eigenvalue is 3.404, and the
explained variance is 37.823%.
Factor 2: There are 3 variables in factor 2,
such as "improving gastrointestinal function" 、
"control of blood lipid “and “reverse
osteoporosis”. Because the factor loading of the
first two factors is higher and more relevant, so
this factor is named "basic health care factor".
The factor loadings are between 0.638 and 0.854,
the eigenvalue is 1.511, and the explained
variance is 16.785%.
Factor 3: There are 2 variables in factor 3,
such as "prevent aging" and "anti-fatigue", so
this factor is named "maintain vitality". The
factor loadings are between 0.621 and 0.827, the
eigenvalue is 1.183, and the explained variance
is 13.142%. The total explained variance of
factor 1, factor 2, and factor 3 is 67.75%
Table. 4-7 Principal component analysis of the trend factors for the future development of the food
biotechnology industry
Variable Factor 1 Factor 2 Factor 3
Microorganisms 0.239 0.323 0.632
Animals 0.017 0.12 0.917
Plants -0.136 0.691 0.301
Vitamins 0.171 0.852 0.166
Minerals 0.617 0.525 -0.291
Containing other functional ingredients 0.856 0.104 0.062
Compound products 0.814 -0.11 0.252
Ming-Lang Wang, Kang-Wei Wang, Int. Jou Eco. Res, 2020, V11 i1, 79 – 98 ISSN:2229-6158
IJER –January -February 2020 available online @ www.ijeronline.com
92
Table. 4-8 Principal component analysis of the main trend factors for the future development of the food
biotechnology industry (Factor Renaming)
Factor 1: There are 3 variables in factor such as
“Containing other functional ingredients” 、
Compound products” and “Minerals”. Because
the factor loading of the first two factors is higher
and more relevant, so this factor is named
"complex products". The factor loadings are
between 0.617 and 0.856, and the eigenvalue is
2.477, and the explained variance is 35.387%.
Factor 2 is composed of two types of high-
relevant variables: "vitamins" and "plants", so this
factor is named "natural products". The factor
loading is between 0.691 and 0.852, the
eigenvalue is 1.491, and the explained variance is
21.304%.
Factor 3 is composed of two types of high-
relevant variables: "animals" and
"microorganisms", so this factor is named "partial
animal products". The factor loadings are between
0.632 and 0.917, the eigenvalue is 1.044, and the
explained variance is 14.917%. The total
explanatory variation of factor 1, factor 2, and 3
three is 71.608%.
Name of Factor Loading Eigenvalue Total explained variance
1. Complex products
Containing other functional ingredients 0.856 2.477 35.387%
Compound products 0.814
Minerals 0.617
2. Natural product
Vitamins 0.852
1.491 21.304%
Plants 0.691
3. Partial animal product
Animals 0.917
1.044 14.917%
Microorganisms 0.632
Ming-Lang Wang, Kang-Wei Wang, Int. Jou Eco. Res, 2020, V11 i1, 79 – 98 ISSN:2229-6158
IJER –January -February 2020 available online @ www.ijeronline.com
93
Table. 4-9 Matrix of products that maintain competitive advantage in the market (PCA after rotation)
Table. 4-10 Principal component analysis of products that maintain competitive advantage in the market
(Factor Renaming)
Factor 1 is mainly composed of five types of high-relevant variables, such as "high-quality
products", "excellent production technology",
"price advantages", "flexible marketing tactics",
and " Brand value beyond peers", named as
"competitive advantages". The factor loadings are
between 0.569 and 0.848, the eigenvalue is 2.613,
and the explained variance is 52.257%.
Variable Factor 1
Price advantage 0.755
Excellent production technology 0.813
High-quality products 0.848
Flexible marketing tactics 0.581
Brand value beyond peers 0.569
Name of Factor Factor loading Eigenvalue Total explained variance
1. Competitive advantages
High-quality products 0.848
2.613 52.257%
Excellent production technology 0.813
Price advantage 0.755
Flexible marketing tactics 0.581
Brand value beyond peers 0.569
Ming-Lang Wang, Kang-Wei Wang, Int. Jou Eco. Res, 2020, V11 i1, 79 – 98 ISSN:2229-6158
IJER –January -February 2020 available online @ www.ijeronline.com
94
Table. 4-11 Principal component analysis of the promotion and development of food biotechnology
industry
Table. 4-12 Principal component analysis of the promotion and development factors of the food
biotechnology industry (Factor Renaming)
Factor 1 is mainly composed of two types of
high-relevant variables, such “product exhibitions
and explanations" and "government’s supports
and funding ". Therefore, this factor is named
"government factor", and its factor loading is
between 0.747 and 0.781, the Eigenvalue is 1.465,
and the explained variance is 29.292%.
Factor2 is composed of two types of high-relevant
variables, "establishing sales networks" and
"share products information through the Internet."
Therefore, this factor is named "network factor".
The factor loadings are between
0.764 and 0.825, the characteristic value is 1.421,
and the explainable variation is 28.423%. The
total explained variance of factor 1 and factor 2 is
57.716%.
5. Conclusions and Recommendations
The current status of the biotechnology
industry in Taiwan is discussed above. Although
the government has actively promoted this
industry in the early days, the shortage of talents
and most of the research and development
technologies used relying on foreign patented
Variable Factor 1 Factor 2
Introduce products in featured articles 0.484 0.328
Product exhibitions 0.781 0.033
Establish sales networks 0.137 0.825
Introduce products online -0.167 0.764
Government’s supports and funding 0.747 -0.255
Name of Factor Factor Loading Eigenvalue Total explainable
variance
1. Government factor
Product exhibitions 0.781
1.465 29.292%
Government’s supports and funding 0.747
2. Internet factor
Establish sales networks 0.825
1.421 28.423%
Share products information through the Internet 0.764
Ming-Lang Wang, Kang-Wei Wang, Int. Jou Eco. Res, 2020, V11 i1, 79 – 98 ISSN:2229-6158
IJER –January -February 2020 available online @ www.ijeronline.com
95
technologies cause slow development in industry
in Taiwan in the future. In terms of talents, today's
society is facing the problem of declining
birthrates. Many colleges and universities
therefore face the challenges to cancel
departments due to few student enrollments.
Therefore, it is a challenge to train the talents.
From a technical point of view, relying on foreign
mature technology, although it can save a lot of
R&D expenditure for enterprises when competing
with international, it will be encountered the
competition of selling similar products when
selling aboard even it is profitable selling in
Taiwan. In addition, there will be many
restrictions when signing licensed technology
with foreign countries due to patent protection
and regulations. The further research and
development will be impeded because of this.
Therefore, it will not help our country to promote
this emerging industry.
The main findings of this study are as follows:
5.1 Discuss the direction of the future
development of food biotechnology. In the future,
which type of product on trend will be
developed?
According to the collected data and the
results of questionnaire analysis of industry
professions, it is learned that the main research
and development of new industrial technologies
tend to be animal derived products. As far as we
know, most of the raw materials for health foods
on the market are derived from animals. It is
produced by extracting the essence of animals.
5.2 How to promote the food biotechnology
industry to let the public understand the demand
and importance of products, so that increase
their willingness to purchase?
Through the analysis of SPSS results, it is
known that the Taiwan’s food biotechnology
industry currently lacks government funds to
support and promote and establish networks for
selling for consumers to search and understand
the effects of products on the Internet based on
their needs to increase consumers trust in food
biotech products to increase their purchase
willingness.
5.3 The conclusions of this study through expert
interviews are as follows:
(1). What is the future development of Taiwan's
food biotechnology industry? Which products
have more potential?
It is not optimistic about the Taiwan market
because of small market size in Taiwan. It is more
difficult to develop the market. Products that are
marketed abroad are mainly healthy and
functional products with more market potential.
In addition to health foods after illness, the
industry can focus on the products preventing
disease in advance.
(2). How can the development of food
biotechnology industry help our country?
In recent times it has become a matter of concern
on health, as well as changes in diet and lifestyle,
and other factors, the general public are more
likely to purchase health food and it promotes
economic development. Although most raw
materials rely on imports, the industry can take
advantage of existing rich agricultural resources
and strengthen the development of ingredients
with innovation to reduce the cost of imported
raw materials and improve competitive
advantages.
(3). Does Taiwan's health food industry transfer
technology abroad?
No. At present, because Taiwan lacks raw
materials, most products rely on foreign imports,
and foreign technology is better than domestic, so
there is no technology transfer so far.
5.4 The conclusions of this study through the
questionnaire survey of practical operators are as
Ming-Lang Wang, Kang-Wei Wang, Int. Jou Eco. Res, 2020, V11 i1, 79 – 98 ISSN:2229-6158
IJER –January -February 2020 available online @ www.ijeronline.com
96
follows:
(1). How to maintain a competitive advantage?
Taiwan’s food and biotechnology products have
been sold in Europe and the United States.
Although it has encountered various difficulties in
sales, it means that our level of production
technology has become closer to advanced
countries. In addition, the industrial clustering
effect and lower tax rates than other countries, it
is believed that Taiwan’s food biotechnology
industry can maintain its advantages under global
competition.
(2). Understanding consumers' product needs can
help the food biotechnology industry. In recent
years, many health food safety issues have
erupted in Taiwan, such as improper labeling and
the use of illegal raw materials. In addition to
discouraging consumer confidence, it has also
prompted the government to tighten the
regulations in health food product raw materials,
production and quality inspection, and standards.
As a result, manufacturers have also begun to
actively understand the importance of consumer
demand for product performance. Through the
results of questionnaire analysis, it was found that
consumers did not have a particular preference for
which product category.
Regarding the future development of the
food biotechnology industry, it is hoped that the
study would provide relevant information for
government or business decision makers, and to
promote policy and R &D directions in the future,
such as which policies and measures should be
promoted and which product category should be
further research and development and so on, line
with international standards and making Taiwan
known internationally for food biotechnology
industry.
REFERENCES
Alison L. Van Eenennaam, (2017), “Genetic
modification of food animals,” Current Opinion
in Biotechnology, Vol. 44, pp.27-34.
Ben-Jeng Wang, (2017), “Community for Long -
Term Care for Elderly People Dining Innovative
Service Model - Take NP Catering group as an
Example,” Tunghai University, Unpublished
Master Thesis of Executive Master of Business
Administration Program.
Biotechnology Industry in Taiwan, (2002),
Bureau of Industry, Ministry of Economic Affairs.
Biotechnology Industry in Taiwan, (2009),
Bureau of Industry, Ministry of Economic Affairs.
Biotechnology Industry in Taiwan, (2011), Bureau
of Industry, Ministry of Economic Affairs.
Biotechnology Industry in Taiwan, (2015),
Bureau of Industry, Ministry of Economic Affairs.
Board of Science and Technology (BOST,
Executive Yuan), (2016).
Chii-Cherng Liao, (2005),”Innovation Research-
Introduction of Emerging Technologies,”
Biotechnology and food industry,” Food Industry
Research and Development Institute. pp.59-p.62.
Guang-Jong Fann, Yuan-Ho Hsu, (2010), “Socio-
Economic Impacts of Population Aging in
Taiwan,” Taiwan Geriatr Gerontol, Vol.5, No.3,
pp.149-168.
Jack Chen, (2001), CTCB Monthly biotechnology
industry report, 1st ed. Taipei.
Jia-Yi Fan, (2016/10/06), “Taiwan's
Biotechnology Industry Status and Future
Development Trends,” http:
//mymkc.com/article/content/22537. [Accessed
12/20/2019]
Julie C.L. Sun, (2003), “Innovation Strategies of
Taiwan's Biotechnology Industry,” Economic
Situation and Review Quarterly, Vol.9, No. 2,
pp.113-139.
Kircher, P.R., et al., (2004), “Doppler ultra-
Ming-Lang Wang, Kang-Wei Wang, Int. Jou Eco. Res, 2020, V11 i1, 79 – 98 ISSN:2229-6158
IJER –January -February 2020 available online @ www.ijeronline.com
97
sonographic evaluation of gastrointestinal
hemodynamics in food hypersensitivities: a
canine model,” Journal of veterinary internal
medicine, Vol.18, No.5, pp. 605-611.
MBA Encyclopedia, SWOT Analysis, [Accessed:
01/20/2020].
Ming-Qing Wu, (1991), Educational Research: An
Analysis of Basic Concepts and Methods, Wu-
Nan Book Inc. Taipei.
Nunnally, J. C. (1978), Psychometric theory, 2nd
ed., McGraw-Hill, New York City.
Pei-Er Han, (1998), The Methodology of Social
Science, Quantification and Qualification Q&A,
Fengyun Forum Co., Ltd., Taipei.
Raju P, (2016), “World History of Modern
Biotechnology and its Applications,”
BioTechnology: An Indian Journal, Vol.12,
No.11. pp.1-8.
Ruo-Huan Yu, (2004),” Analysis of the
Government's Expression of TV News”,
Unpublished Master Thesis of Department of
Journalism, Chinese Culture University.
Shi-Ying Yang, (2015), Statistical Analysis
Guidebook Using SPSS, Flag Technology Co.,
Ltd., Taipei.
Shu-Yen Chiang, (2015). “A Study on the Product
Function and Involvement of Health Foods
Affecting Consumers’ Purchase Intention – The
Consumers’ Age as a Moderator”, Unpublished
Master Thesis of Department of International
Trade, Chinese Culture University.
Wane S. Chou, (2002), Multivariate Statistical
Analysis: with Application of SAS / STAT.
BestWise Co., Ltd., Taipei.
Wen-Long Wan, (2004), “Application of in-depth
interviews in qualitative research,” Life
Technology Education, Vol.37, No.4, pp.17-23.
Yang Guoshu, Wen Chongyi, Wu Congxian, Li
Yiyuan, (2000), Social and Behavioral
ScienceResearch Methodology Book 2, Tung Hua
Book Co., Ltd, Taipei.
Ye arbook of Applied Biotechnology Industry,
(2016), Development Center for Biotechnology.
Ming-Lang Wang, Kang-Wei Wang, Int. Jou Eco. Res, 2020, V11 i1, 79 – 98 ISSN:2229-6158
IJER –January -February 2020 available online @ www.ijeronline.com
98